The editors from The Journal of Clinical Endocrinology & Metabolism share their picks for the top breakthroughs in endocrine science from 2022. Editor-in-chief of JCEM, Paul M. Stewart, MD, FRCP, FMedSci, executive dean and professor at the University of Leeds School of Medicine in the United Kingdom says he “wanted something of an evidence to...
Higher Prevalence of Evening Chronotype in Women with PCOS Associated with Worse Metabolic Profile
A higher prevalence of the evening chronotype in women with polycystic ovary syndrome (PCOS) is associated with a worse hormonal and metabolic profile, according to a paper recently published in the Journal of Pineal Research. Researchers led by Giovanna Muscogiuri, MD, PhD, an assistant professor in the Unit of Endocrinology at Federico II University Medical...
After years of being told that there were no other scientists out there “who looked like him,” Antentor Hinton, Jr., PhD, made it his mission to increase diversity in research labs everywhere he could. By mentoring up and coming scientists, championing DEI, and even creating the 1,000 Inspiring Black Scientists of America list in the...
The editors from The Journal of the Endocrine Society share their picks for the top endocrine discoveries of 2022. For Journal of the Endocrine Society editor-in-chief Zeynep Madak-Erdogen, PhD, associate professor of nutrition; Sylvia D. Stroup Scholar at the University of Illinois Urbana-Champaign, “Operation of a TCA Cycle Subnetwork in the Mammalian Nucleus” was a...
The editors from the Endocrine Society journal, Endocrinology, share their top picks for the outstanding endocrine discoveries of 2022. From the Editor-in-Chief of Endocrinology Editor-in-chief Carol A. Lange, PhD, professor of medicine (Division of Hematology, Oncology, and Transplantation) and pharmacology; Tickle Family Land Grant Endowed Chair of Breast Cancer Research; co-lead, Cellular Mechanisms of Cancer...
New Endocrine Society Guideline Suggests Hypercalcemia of Malignancy Treatment Options
Protocols for treating this common cancer complication are provided in latest Clinical Practice Guideline Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society’s new Clinical Practice Guideline. The guideline, titled “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society...
Endocrine News talks to editors from the Endocrine Society journal, Endocrine Reviews, to unearth the endocrine nuggets of 2022! This may go down as the “Gold Rush of ’22.” Maybe because researchers were more fully able to return to their labs this year after facing pandemic-related challenges for so long, or maybe just because it...Q&A: Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD
Endocrine News talks with Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating hypercalcemia of malignancy. Hypercalcemia of malignancy (HCM) is the most common metabolic complication of cancer, but its incidence may be declining due to...
